Skip to content

Author

Reham Ghazwani

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

2026

Intravenous ketamine compared to intranasal esketamine for treatment-resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes

Treatment-resistant depression (TRD) represents a significant therapeutic challenge in psychiatry. While both intravenous (IV) ketamine and intranasal (IN) esketamine have been raised as promising medical treatments for TRD, their comparative efficacy and safety profiles remain unclear. This meta-analysis aimed to eval...

O. Aldoweesh, Reham Ghazwani, Joud Aldhahery et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.